Does Arginine-Calcium-Saw Palm-Hb73 Tablet Interact with other Medications?
Severe Interactions
These medications are not usually taken together. Consult your healthcare professional (e.g., doctor or pharmacist) for more in formation.
Serious Interactions
These medications may interact and cause very harmful effects. Consult your healthcare professional (e.g., doctor or pharmacist) for more in formation.
- CYP3A4 INDUCERS/ZURANOLONE
- P-GLYCOPROTEIN (P-GP) INHIBITORS/PRALSETINIB
- CYP3A4 INDUCERS/ERLOTINIB
- P-GLYCOPROTEIN (P-GP) INHIBITORS/BILASTINE
- SELECTED MODERATE AND WEAK CYP1A2 INHIBITORS/TIZANIDINE
- CYP3A4 INDUCERS/ATOGEPANT
- P-GLYCOPROTEIN (P-GP) INHIBITORS/DOXORUBICIN
- P-GLYCOPROTEIN (P-GP) INHIBITORS/RELUGOLIX
- CYP3A4 INDUCERS/LUMATEPERONE
- P-GLYCOPROTEIN (P-GP) INHIBITORS/ORAL LEFAMULIN
- SERUM PHOSPHATE LEVEL-ALTERING DRUGS/ERDAFITINIB
- SELECTED P-GLYCOPROTEIN (P-GP) INHIBITORS/VENETOCLAX
- SELECTED INHIBITORS OF P-GP OR BCRP/PAZOPANIB
- P-GLYCOPROTEIN (P-GP) INHIBITORS/TOPOTECAN
- SELECTED P-GLYCOPROTEIN (P-GP) INHIBITORS/DABIGATRAN
- ALUM;CA;MAG/ORAL PHOSPHATE SUPPLEMENTS; URINARY PH MODIFIERS
Moderate Interactions
These medications may cause some risk when taken together. Consult your healthcare professional (e.g., doctor or pharmacist) for more in formation.
- SLT CATION-DONATING ANTACIDS/POLYSTYRENE SULFONATE
- ANTACIDS/CEFPODOXIME
- POLYVALENT CATIONS AND PHOSPHATE BINDERS/VADADUSTAT
- ANTACIDS/NIROGACESTAT
- ANTACIDS/SPARSENTAN
- MODERATE AND WEAK CYP3A4 INDUCERS/TACROLIMUS
- ANTACIDS/LEVOKETOCONAZOLE
- POLYVALENT CATIONS/ROXADUSTAT
- ANTACIDS/SOTORASIB
- POLYVALENT CATIONS/CABOTEGRAVIR
- ANTACIDS/INFIGRATINIB; SELPERCATINIB
- MODERATE AND WEAK CYP3A4 INDUCERS/UBROGEPANT
- SELECTED MINERALS, ORAL/TRIENTINE
- POLYVALENT CATIONS/BALOXAVIR
- SELECT P-GP INHIBITORS/EDOXABAN (<= 30 MG)
- CALCIUM & IRON CONTAINING SUPPLEMENTS/BICTEGRAVIR
- SEL ORAL CATIONS; ANTACIDS; H2 ANTAG/DOLUTEGRAVIR-RILPIVIRIN
- SELECTED P-GLYCOPROTEIN (P-GP) INHIBITORS/BETRIXABAN
- SELECT P-GP INHIBITORS/EDOXABAN (> 30 MG)
- ANTACIDS; H2 ANTAGONISTS/LEDIPASVIR; VELPATASVIR
- SELECTED CYP1A2 INHIBITORS/THEOPHYLLINE DERIVATIVES
- SELECTED MODERATE-WEAK CYP3A4 INDUCERS/EXEMESTANE
- ANTACIDS/RIOCIGUAT
- SELECTED ORAL CATIONS/DOLUTEGRAVIR
- P-GLYCOPROTEIN (P-GP) INHIBITORS/AFATINIB
- SELECTED ORAL CATIONS/ELVITEGRAVIR
- ANTACIDS/SELECTED CEPHALOSPORINS
- SELECTED ORAL CATIONS/SELECTED ORAL QUINOLONES
- POLYVALENT CATIONS/ELTROMBOPAG
- ALUMINUM-MAGNESIUM HYDROXIDE; ORAL CALCIUM/PHENYTOIN
- ANTACIDS AND SELECTED MINERALS/ORAL IRON SUPPLEMENTS
- DI-; TRIVALENT CATIONS/CHLOROQUINE; HYDROXYCHLOROQUINE
- ORAL CALCIUM PRODUCTS/ESTRAMUSTINE
- ORAL CALCIUM PRODUCTS/STRONTIUM
- SELECTED CHELATION AGENTS/THYROID PREPARATIONS
- DIVALENT & TRIVALENT CATIONS/TETRACYCLINES
Selected from data included with permission and copyrighted by First Databank, Inc. This copyrighted material has been downloaded from a licensed data provider and is not for distribution, except as may be authorized by the applicable terms of use.
CONDITIONS OF USE: The information in this database is intended to supplement, not substitute for, the expertise and judgment of healthcare professionals. The information is not intended to cover all possible uses, directions, precautions, drug interactions or adverse effects, nor should it be construed to indicate that use of a particular drug is safe, appropriate or effective for you or anyone else. A healthcare professional should be consulted before taking any drug, changing any diet or commencing or discontinuing any course of treatment.